[1] Folkman J, Merler E, Abernathy C, et al. Isolation of a tumor factor responsible or angiogenesis[J]. J Exp Med, 1971, 133(2): 275-88. [2] Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J]. Cancer Res,2000, 60(5): 1306-11. [3] Sawaoka H, Tsuji S, Tsujii M, et al. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo[J]. Lab Invest,1999, 79(12): 1469-77. [4] Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis andmetastasis: correlation in invasive breast carcinoma[J]. New Eng J Med, 1991, 324(1): 1-8 [5] Breasalier RS, HO SB, Schoeppner HL, et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis[J]. Gastroenterology, 1996, 110(5): 1354-67. [6] Frelin C, Ladoux A, D’angelo G. Vascular endothelial growth factors and angiogenesis[J]. Ann Endocrinol (Paris), 2000, 61(1): 70-4. [7] Gerwins P, Skoldenberg E, Claesson WL, et al. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis[J]. Crit Rev Oncol Hematol, 2000,34(3): 185-94. [8] Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells[J]. Cell, 1998, 93(5): 705-16. [9] Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing[J]. Nat Med,1999, 5(12): 1418-23. [10] Ristimkai A, Honkanen N, Jankala H, et al. Expression of cyclooxygenase-2 in human gastric carcinoma[J]. Cancer Res, 1997, 57 (7):1276-80. [11] Pai R, Szabo IL, Kawanaka H, et al. Indomethacin inhibits endothelial cell proliferation by suppressing cell cycle proteins and PRB phosphorylation. A key to its anti-angioganic action[J]? Mol Cell Biol Res Commun, 2001, 4(1): 111-6. [12] Kawai N, Tsujii M, Tsuji S. Cyclooxygenases and colon cancer[J].Prostaglandins Other Lipid Mediat, 2002, 68-69: 187-96. [13] Leahy KM, Ornberg RL, Wang Y, et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelisl cells in vivo[J]. Cancer Res, 2002, 62(3):625-31. [14] Tarnawski AS, Jones MK. Inhibition of angiogenesis by NSAIDs:molecular mechanisms and clinical implications[J]. J Mol Med,2003, 81(10): 627-36. [15] Ma L, del Soldato D, Wallace JL. Divergent effects of new cyclooxygenase inhibitors on gastriculcer healing: shifting the angiogenic balance[J]. Proc Natl Acad Sci USA, 2002, 99(20): 13243-7. |